8RNE
HLA-E*01:03 in complex with SARS-CoV-2 Nsp13 peptide, VMPLSAPTL
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | MAX IV BEAMLINE BioMAX |
| Synchrotron site | MAX IV |
| Beamline | BioMAX |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2023-06-09 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.97625 |
| Spacegroup name | C 1 2 1 |
| Unit cell lengths | 120.493, 67.597, 152.228 |
| Unit cell angles | 90.00, 92.78, 90.00 |
Refinement procedure
| Resolution | 46.110 - 1.710 |
| Rwork | 0.204 |
| R-free | 0.24330 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.006 |
| RMSD bond angle | 1.469 |
| Data reduction software | XDS |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | REFMAC (5) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 46.110 | 1.740 |
| High resolution limit [Å] | 1.710 | 1.710 |
| Rmerge | 0.070 | 1.252 |
| Rmeas | 0.083 | |
| Rpim | 0.044 | 0.774 |
| Number of reflections | 132063 | 6521 |
| <I/σ(I)> | 11.7 | 1.4 |
| Completeness [%] | 99.9 | 100 |
| Redundancy | 2 | |
| CC(1/2) | 0.999 | 0.628 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 293.15 | 0.15 M potassium bromide, 20% w/v of PEG 2000 MME |






